touchLearning Activities
Education, Conference Coverage and Articles
New 52-week REZOLVE-AD data showed durable responses with monthly and quarterly rezpegaldesleukin (REZPEG) maintenance dosing in atopic dermatitis. Prof. Thomas Bieber discusses the findings and the potential for long-term remission and disease modification, highlighting the further evidence needed to explore these goals.
Could glucagon-like peptide-1 receptor agonists affect nail health? A multinational study presented at EADV 2026 found nail disorders were reported more frequently among users, with nearly sevenfold higher odds of nail detachment. Prof. Bianca Maria Piraccini discusses the findings and why further clinical assessment is needed.
From pruritus and burn scars to cutaneous neurofibromas, Prof. Ashraf Badawi explores some of the new directions for lasers and energy-based devices discussed at this years EADV congress.
How does bimekizumab perform in everyday clinical practice? An Italian multicenter study reported improvements in disease activity, pain, and quality of life in people with hidradenitis suppurativa, with no unexpected safety signals. Dr Mario Valenti shares the findings and his perspective with touchDERMATOLOGY.
Encouraging findings from JAKPPPOT support the feasibility of a definitive randomized controlled trial of Janus kinase inhibitors in palmoplantar pustulosis and provide an exploratory estimate of treatment effect. We spoke with Dr David Gleeson about the results presented at EADV 2026 and their implications for future research.
RLS-1496 1% cream (Rubedo Life Sciences, CA, USA) is an investigational senotherapeutic treatment that selectively and potently inhibits the antioxidant enzyme glutathione peroxidase 4 (GPX4). It aims to target senescent cells, potentially offering a new approach to treating AK.2 Results from a phase 1b/2a, multicenter, open-label clinical study of RLS-1496 1% cream were presented during a late-breaking session at the European Academy of Dermatology and Venereology (EADV) Congress 2026.
Dr Maria-Angeliki Gkini explores the growing role of psychodermatology in supporting patients’ wider needs, alongside emerging technologies and approaches that could shape the future management of psoriatic disease.
Meet the dermatologists redefining the future of practice, research, and technology Meet the innovators shaping the future of dermatology The touchDERMATOLOGY Future Leaders 2026 have been nominated and selected to recognize the rising stars shaping the future of across the field ...
We are delighted to announce Dr Dennis Niebel as a touchDERMATOLOGY Future Leader 2026, selected for his contributions to immune-mediated skin disorders and sustainable dermatology. Germany-based Dr Dennis Niebel is a Lecturer and Consultant Dermatologist at the University of Cologne (Cologne, ...
We are delighted to announce Dr Dimitri Luz as a touchDERMATOLOGY Future Leader 2026. Dr Luz is helping to advance immune-mediated dermatology through his work in clinical care, research, and medical education. A Brazilian-trained dermatologist now based in Perth, Australia, his ...
We are delighted to announce Dr Zoë Venables as a touchDERMATOLOGY Future Leader 2026. Dr Zoë Venables is a Consultant Dermatologist and Clinical Associate Professor at the University of East Anglia, Norwich, UK. She is Clinical Lead for Dermatology at NHS ...
We are delighted to welcome Dr Brittany Dulmage as a touchDERMATOLOGY Future Leader 2026. Brittany Dulmage, MD, FAAD, is a US board-certified dermatologist and Associate Professor of Dermatology at The Ohio State University (OSU) Wexner Medical Center in Columbus, OH, USA. ...
We are delighted to announce Dr Samar Khalil as a touchDERMATOLOGY Future Leader 2026. Dr Khalil is a general and cosmetic dermatologist practicing at Skin Experts Polyclinic in Dubai, United Arab Emirates, and Skin Clinic in Beirut, Lebanon. She completed her ...
We are delighted to welcome Dr Indrashis Podder as a touchDERMATOLOGY Future Leader 2026. Dr Podder is Assistant Professor of Dermatology at the College of Medicine & Sagore Dutta Hospital in Kolkata, India, with a particular clinical and research interest in ...
We are delighted to introduce Dr Olufolakemi Cole-Adeife as a touchDERMATOLOGY Future Leader 2026. Dr Cole-Adeife is a Consultant Physician, Dermatologist and Venereologist at Lagos State University Teaching Hospital (LASUTH) and a Lecturer at Lagos State University College of Medicine in ...
We are delighted to announce Dr Anastasiya Muntyanu as a touchDERMATOLOGY Future Leader 2026. Based in Toronto, Canada, Anastasiya Muntyanu, MD, PhD, FRCPC, FAAD, is a Canadian and US board-certified dermatologist practising at the Women's College Hospital and the Princess Margaret ...
We are delighted to announce Dr Martyna Sławińska as a touchDERMATOLOGY Future Leader 2026. Dr Martyna Sławińska is advancing the field of dermatology through her work on non-invasive skin imaging and its application beyond skin cancer. Based ...
touchDERMATOLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
